research 378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research Embryology, Histology, and Physiology of the Hair Follicle
The document explains how hair follicles develop, their structure, and how they grow.
research The impact of hair care practices and attitudes toward hair management on exercise habits in African American women
Hair care practices and concerns about maintaining hairstyles can reduce how often African American women exercise.
research Hair Mesotherapy in Treatment of Alopecia
Hair mesotherapy showed improvement in hair growth and thickness without side effects.
research Efficacy and Safety of EqualsTwo Oil Free Hair Oil in Pregnant and Lactating Women: An Open-Label, Single-Arm Clinical Study
EqualsTwo Anti-Hair Fall Mist Spray is safe and effective for reducing hair fall in pregnant and lactating women.
research Formulation and evaluation of herbal hair serum with flower extract of Bougainvillea glabra
The herbal hair serum with Bougainvillea glabra extract is safe and effective for hair growth and scalp health.
research Chitosan in Aesthetic Practice: A Clinical Narrative Review of Skin, Scar, and Scalp Applications
Chitosan shows promise for skin and scalp treatments but needs more research.
research The Scalp as a Donor Site in Pediatric Burns: Systematic Review of the Literature and Proposal of a Management Algorithm
The scalp is a safe and effective donor site for skin grafts in children with burns.
research Efficacy of Scalp Cooling System Versus Chemical Cooling Cap in Preventing Chemotherapy-induced Alopecia in Breast Cancer (COHAIR Study): a prospective randomized trial
Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.
research Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.